María Teresa Miras-Portugal

María Teresa Miras-Portugal

Auto-generated profile, based on publicly available information

María Teresa Miras-Portugal

Departamento de Bioquímica y Biología Molecular, Facultad de Veterinaria, Instituto Universitario de Investigación en Neuroquímica (IUIN), Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdiSSC), Universidad Complutense Madrid, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RPRaquel Pérez-Sen
Raquel Pérez-Sen
MQMaría José Queipo
María José Queipo
JGJuan Carlos Gil-Redondo
Juan Carlos Gil-Redondo
Felipe OrtegaFelipe Ortega
Felipe Ortega
Rosa Gomez-VillafuertesRosa Gomez-Villafuertes
Rosa Gomez-Villafuertes
EDEsmerilda García Delicado
Esmerilda García Delicado
Dual-specificity protein phosphatases comprise a protein phosphatase subfamily with selectivity towards mitogen-activated protein (MAP) kinases, also named MKPs, or mitogen-activated protein kinase (MAPK) phosphatases. As powerful regulators of the intensity and duration of MAPK signaling, a relevant role is envisioned for dual-specificity protein phosphatases (DUSPs) in the regulation of biological processes in the nervous system, such as differentiation, synaptic plasticity, and survival. Important neural mediators include nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) that contribute to DUSP transcriptional induction and post-translational mechanisms of DUSP protein stabilization to maintain neuronal survival and differentiation. Potent DUSP gene inducers also include cannabinoids, which preserve DUSP activity in inflammatory conditions. Additionally, nucleotides activating P2X7 and P2Y13 nucleotide receptors behave as novel players in the regulation of DUSP function. They increase cell survival in stressful conditions, regulating DUSP protein turnover and inducing DUSP gene expression. In general terms, in the context of neural cells exposed to damaging conditions, the recovery of DUSP activity is neuroprotective and counteracts pro-apoptotic over-activation of p38 and JNK. In addition, remarkable changes in DUSP function take place during the onset of neuropathologies. The restoration of proper DUSP levels and recovery of MAPK homeostasis underlie the therapeutic effect, indicating that DUSPs can be relevant targets for brain diseases.

17 August 2017
Verified
Book Chapter
Closed access
PDF file
RPRaquel Pérez-Sen
Raquel Pérez-Sen
Rosa Gomez-VillafuertesRosa Gomez-Villafuertes
Rosa Gomez-Villafuertes
Felipe OrtegaFelipe Ortega
Felipe Ortega
JGJavier Gualix
Javier Gualix
EDEsmerilda García Delicado
Esmerilda García Delicado
MMMaría Teresa Miras-Portugal
María Teresa Miras-Portugal

1 January 2015 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
MMM. Teresa Miras-Portugal
M. Teresa Miras-Portugal
JDJuan I. Diaz-Hernandez
Juan I. Diaz-Hernandez
Rosa Gomez-VillafuertesRosa Gomez-Villafuertes
Rosa Gomez-Villafuertes
Miguel Diaz-HernandezMiguel Diaz-Hernandez
Miguel Diaz-Hernandez
Antonio R. ArtalejoAntonio R. Artalejo
Antonio R. Artalejo
JGJavier Gualix
Javier Gualix
Amyloid precursor protein (APP) is expressed in a large variety of neural and non-neural cells. The balance between non-pathogenic and pathologic forms of APP processing, mediated by α-secretase and β-secretase respectively, remains a crucial step to understand β-amyloid, Aβ42 peptide, formation and aggregation that are at the origin of the senile plaques in the brain, a characteristic hallmark of Alzheimer's disease (AD). In Neuro-2a, a neuroblastoma cell line that constitutively expresses APP, activation of the P2X7 receptor leads to reduction of α-secretase activity, the opposite effect being obtained by P2Y2 receptor activation. The in vivo approach was made possible by the use of J20 mice, a transgenic mouse model of familial Alzheimer's disease (FAD) expressing human APP mutant protein. This animal exhibits prominent amyloid plaques by six months of age. In vivo inhibition of the P2X7 receptor induced a significant decrease in the number and size of hippocampal amyloid plaques. This reduction is mediated by an increase in the proteolytic processing of APP through α-secretase activity, which correlates with an increase in the phosphorylated form of GSK-3, a less active form of this enzyme. The in vivo findings corroborate the therapeutic potential of P2X7 antagonists in the treatment of FAD.

22 December 2017 in Frontiers in Pharmacology
Verified
Journal Article
Open access
AMAida Menéndez-Méndez
Aida Menéndez-Méndez
JDJuan I. Díaz-Hernández
Juan I. Díaz-Hernández
Felipe OrtegaFelipe Ortega
Felipe Ortega
JGJavier Gualix
Javier Gualix
Rosa Gomez-VillafuertesRosa Gomez-Villafuertes
Rosa Gomez-Villafuertes
MMMaría T. Miras-Portugal
María T. Miras-Portugal
Adenosine triphosphate (ATP) is an important extracellular neurotransmitter that participates in several critical processes like cell differentiation, neuroprotection or axon guidance. Prior to its exocytosis, ATP must be stored in secretory vesicles, a process that is mediated by the Vesicular Nucleotide Transporter (VNUT). This transporter has been identified as the product of the SLC17A9 gene and it is prominently expressed in discrete brain areas, including the cerebellum. The main population of cerebellar neurons, the glutamatergic granule neurons, depends on purinergic signaling to trigger neuroprotective responses. However, while nucleotide receptors like P2X7 and P2Y13 are known to be involved in neuroprotection, the mechanisms that regulate ATP release in relation to such events are less clearly understood. In this work, we demonstrate that cerebellar granule cells express a functional VNUT that is involved in the regulation of ATP exocytosis. Numerous vesicles loaded with this nucleotide can be detected in these granule cells and are staining by the fluorescent ATP-marker, quinacrine. High potassium stimulation reduces quinacrine fluorescence in granule cells, indicating they release ATP via calcium dependent exocytosis. Specific subcellular markers were used to assess the localization of VNUT in granule cells, and the transporter was detected in both the axonal and somatodendritic compartments, most predominantly in the latter. However, co-localization with the specific lysosomal marker LAMP-1 indicated that VNUT can also be found in non-synaptic vesicles, such as lysosomes. Interestingly, the weak co-localization between VNUT and VGLUT1 suggests that the ATP and glutamate vesicle pools are segregated, as also observed in the cerebellar cortex. During post-natal cerebellar development, VNUT is found in granule cell precursors, co-localizing with markers of immature cells like doublecortin, suggesting that this transporter may be implicated in the initial stages of granule cell development.

11 January 2021 in Brain Structure and Function
Verified
Journal Article
Open access
PDF file
Felipe OrtegaFelipe Ortega
Felipe Ortega
RGRosa Gomez-Villafuertes
Rosa Gomez-Villafuertes
MBMaría Benito-León
María Benito-León
MTMargaret Martínez de la Torre
Margaret Martínez de la Torre
LOLuis A. Olivos-Oré
Luis A. Olivos-Oré
MMMaría Teresa Miras-Portugal
María Teresa Miras-Portugal
The purinergic system is one of the oldest cell-to-cell communication mechanisms and exhibits relevant functions in the regulation of the central nervous system (CNS) development. Amongst the components of the purinergic system, the ionotropic P2X7 receptor (P2X7R) stands out as a potential regulator of brain pathology and physiology. Thus, P2X7R is known to regulate crucial aspects of neuronal cell biology, including axonal elongation, path-finding, synapse formation and neuroprotection. Moreover, P2X7R modulates neuroinflammation and is posed as a therapeutic target in inflammatory, oncogenic and degenerative disorders. However, the lack of reliable technical and pharmacological approaches to detect this receptor represents a major hurdle in its study. Here, we took advantage of theP2rx7-EGFP reporter mouse, which expresses enhanced green fluorescence protein (EGFP) immediately downstream of theP2rx7proximal promoter, to conduct a detailed study of its distribution. We performed a comprehensive analysis of the pattern of P2X7R expression in the brain of E18.5 mouse embryos revealing interesting areas within the CNS. Particularly, strong labelling was found in the septum, as well as along the entire neural roof plate zone of the brain, except chorioidal roof areas, but including specialized circumventricular roof formations, such as the subfornical and subcommissural organs (SFO; SCO). Moreover, our results reveal what seems a novel circumventricular organ, named by us postarcuate organ (PArcO). Furthermore, this study sheds light on the ongoing debate regarding the specific presence of P2X7R in neurons and may be of interest for the elucidation of additional roles of P2X7R in the idiosyncratic histologic development of the CNS and related systemic functions.